Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance Through the CXCL12/CXCR4/mTOR/TGFβ Signaling Pathway in Breast Cancer Cells
出版年份 2020 全文链接
标题
Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance Through the CXCL12/CXCR4/mTOR/TGFβ Signaling Pathway in Breast Cancer Cells
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 3, Pages 805
出版商
MDPI AG
发表日期
2020-01-27
DOI
10.3390/ijms21030805
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization
- (2019) Meisi Yan et al. Cell Death & Disease
- CD26/DPP4 - a potential biomarker and target for cancer therapy
- (2019) Njanja Enz et al. PHARMACOLOGY & THERAPEUTICS
- Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription
- (2018) Shuai Chen et al. BRITISH JOURNAL OF CANCER
- The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
- (2018) Keizo Kanasaki CLINICAL SCIENCE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer
- (2018) Joshua W. Russo et al. CANCER RESEARCH
- mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer
- (2018) Shun-Qing Liang et al. ONCOGENE
- Inhibition of dipeptidyl peptidase-4 accelerates epithelial-mesenchymal transition and breast cancer metastasis via the CXCL12/CXCR4/mTOR axis
- (2018) Fan Yang et al. CANCER RESEARCH
- Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
- (2018) Devin Abrahami et al. BMJ-British Medical Journal
- ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
- (2017) Romana-Rea Begicevic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Snail maintains metastatic potential, cancer stem-like properties, and chemoresistance in mesenchymal mouse breast cancer TUBO-P2J cells
- (2017) Sun Young Ma et al. ONCOLOGY REPORTS
- Epithelial-mesenchymal transition: potential regulator of ABC transporters in tumor progression
- (2017) Zong-Sheng Jiang et al. Journal of Cancer
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer
- (2016) Yang Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oncogenic roles of EMT-inducing transcription factors
- (2014) Alain Puisieux et al. NATURE CELL BIOLOGY
- CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis
- (2014) Yanan Sun et al. TUMOR BIOLOGY
- Cancer biology in diabetes
- (2014) Shi Sen et al. Journal of Diabetes Investigation
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- The dynamics of drug resistance: A mathematical perspective
- (2012) Orit Lavi et al. DRUG RESISTANCE UPDATES
- Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein
- (2012) Wei-Juan Chen et al. Chinese Journal of Cancer
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
- (2011) M Saxena et al. Cell Death & Disease
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells
- (2009) Hiroaki Kajiyama et al. CANCER SCIENCE
- Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells
- (2009) Q.-Q. Li et al. CLINICAL CANCER RESEARCH
- Incretin-Based Therapies: Viewpoints on the way to consensus
- (2009) Michael. A. Nauck et al. DIABETES CARE
- Diabetes and cancer
- (2009) Paolo Vigneri et al. ENDOCRINE-RELATED CANCER
- An ABC Transporter Controls Export of a Drosophila Germ Cell Attractant
- (2009) S. Ricardo et al. SCIENCE
- Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation
- (2008) W T Arscott et al. ONCOGENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started